These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38104275)

  • 1. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals.
    López-Estévez AM; Lapuhs P; Pineiro-Alonso L; Alonso MJ
    Adv Mater; 2024 Apr; 36(14):e2309355. PubMed ID: 38104275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotherapeutics for the Treatment of Cancer and Arthritis.
    Patel P; Meghani N; Kansara K; Kumar A
    Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy.
    Zheng M; Tao W; Zou Y; Farokhzad OC; Shi B
    Trends Biotechnol; 2018 May; 36(5):562-575. PubMed ID: 29422412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
    Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
    Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in nanoparticle-mediated siRNA delivery.
    Williford JM; Wu J; Ren Y; Archang MM; Leong KW; Mao HQ
    Annu Rev Biomed Eng; 2014 Jul; 16():347-70. PubMed ID: 24905873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision arrows: Navigating breast cancer with nanotechnology siRNA.
    Jayaswal N; Srivastava S; Kumar S; Belagodu Sridhar S; Khalid A; Najmi A; Zoghebi K; Alhazmi HA; Mohan S; Tambuwala MM
    Int J Pharm; 2024 Sep; 662():124403. PubMed ID: 38944167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry and formulations for siRNA therapeutics.
    Gallas A; Alexander C; Davies MC; Puri S; Allen S
    Chem Soc Rev; 2013 Oct; 42(20):7983-97. PubMed ID: 23857524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology-based cancer therapeutics--promise and challenge--lessons learned through the NCI Alliance for Nanotechnology in Cancer.
    Farrell D; Ptak K; Panaro NJ; Grodzinski P
    Pharm Res; 2011 Feb; 28(2):273-8. PubMed ID: 20814720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA applications in nanomedicine.
    Tokatlian T; Segura T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(3):305-15. PubMed ID: 20135697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.
    Li Y; Wang J; Wientjes MG; Au JL
    Adv Drug Deliv Rev; 2012 Jan; 64(1):29-39. PubMed ID: 21569804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural product-based nanomedicine: recent advances and issues.
    Watkins R; Wu L; Zhang C; Davis RM; Xu B
    Int J Nanomedicine; 2015; 10():6055-74. PubMed ID: 26451111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.
    Kievit FM; Zhang M
    Adv Mater; 2011 Sep; 23(36):H217-47. PubMed ID: 21842473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.
    Taratula O; Garbuzenko O; Savla R; Wang YA; He H; Minko T
    Curr Drug Deliv; 2011 Jan; 8(1):59-69. PubMed ID: 21034421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
    Kumari A; Kumar V; Yadav SK
    Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles as protein and gene carriers to mucosal surfaces.
    de la Fuente M; Csaba N; Garcia-Fuentes M; Alonso MJ
    Nanomedicine (Lond); 2008 Dec; 3(6):845-57. PubMed ID: 19025458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.